Bracco is focused on contrast imaging and committed to quality contrast agents and relaxivity research, providing continuing education and technological support. One of the key areas of our recent innovations which we believe may draw your attention is Magnetic Resonance Imaging, the modality with increasing impact on overall patient management.
We are pleased to invite you to the educational webinar taking place virtually on November 17, 2026 at 6PM CET.
Advancing Breast MRI:
Selecting the Right Contrast Agent
in routine clinical practice
Michael Fuchsjäger
President of EUSOBI and Chairman of Radiology Department at Medical University of Graz (AT)
Gunter Erb
Global Medical Affairs
at Bracco
Daniela Bernardi
Head of Breast Imaging and Screening Unit,
IRCCS Humanitas Research Hospital, Milan (IT);
Associate Professor of Radiology,
Humanitas University, Milan (IT)
Paola Clauser
Professor of Radiology, at
Medical University, Vienna (AT)
Watch the video with all our faculty.
The webinar will explore the role of high-relaxivity contrast agent Gadopiclenol in breast MRI. After a welcome by Michael Fuchsjäger President of EUSOBI Gunter Erb will introduce the molecule Gadopiclenol. Daniela Bernardi and Paola Clauser will then share their clinical experience with Gadopiclenol, focusing on its use in breast cancer screening, diagnostic setting and neoadjuvant chemotherapy. They will discuss how Gadopiclenol will positively contribute to the future of breast imaging by improving lesion detection.
The webinar will also feature a Live Q&A session, offering attendees the chance to engage directly with the faculty. The webinar, which will be held in English, will be hosted by the EUSOBI channel.
Educational materials, symposia and webinars, lectures, fellowship programs and scholarships Ongoing opportunities for your professional development.
GL-VW-2600040